ES2133454T3 - Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles. - Google Patents

Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles.

Info

Publication number
ES2133454T3
ES2133454T3 ES94113877T ES94113877T ES2133454T3 ES 2133454 T3 ES2133454 T3 ES 2133454T3 ES 94113877 T ES94113877 T ES 94113877T ES 94113877 T ES94113877 T ES 94113877T ES 2133454 T3 ES2133454 T3 ES 2133454T3
Authority
ES
Spain
Prior art keywords
lysinates
effervescent
insoluble
mix
hardly soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94113877T
Other languages
English (en)
Inventor
Gerhard Dr Gergely
Thomas Dr Gergely
Irmgard Gergely
Stefan Dr Gergely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2133454T3 publication Critical patent/ES2133454T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/82—Acid flavourants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

LA MEZCLA EFERVESCENTE CONTIENE AL MENOS UNA SUSTANCIA ACTIVA FARMACEUTICA ACIDA, INSOLUBLE O DIFICILMENTE SOLUBLE EN FORMA DE SU SAL ALCALINA SOLUBLE O LISINATO, QUE EN UNA MEZCLA INTIMA ESTA PRESENTE CON EL COMPONENTE ALCALINO Y CON PREFERENCIA ENVUELTO CON LAS PARTICULAS DEL COMPONENTE ALCALINO DEL SISTEMA EFERVESCENTE, POR EJEMPLO BICARBONATO DE SODIO Y/O CARBONATO DE SODIO. AMBOS COMPONENTES PUEDEN TAMBIEN ESTAR PRESENTES DE FORMA PULVERIZADA FINA CON LA AYUDA DE UN AGLOMERANTE COMO GRANULADO. LA MEZCLA EFERVESCENTE CONTIENE ESPECIALMENTE SOBRE 100 PARTES DE SUSTANCIA ACTIVA AL MENOS 0,5, CON PREFERENCIA DESDE 1 HASTA 3 PARTES DE UN SURFACTANTE, ESPECIALMENTE DIOCTIL SULFOSUCINATO, Y/O AL MENOS 1, CON PREFERENCIA 3 HASTA 5 PARTES DE UN MEDIO AGLOMERANTE O MEDIO AUXILIAR DE SUSPENSION, EN PARTICULAR POLIVINIL PIRROLIDON. EL COMPONENTE ACIDO DEL SISTEMA EFERVESCENTE ESTA PASIVADO SUPERFICIALMENTE.
ES94113877T 1993-09-07 1994-09-05 Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles. Expired - Lifetime ES2133454T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH265293 1993-09-07

Publications (1)

Publication Number Publication Date
ES2133454T3 true ES2133454T3 (es) 1999-09-16

Family

ID=4238568

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94113877T Expired - Lifetime ES2133454T3 (es) 1993-09-07 1994-09-05 Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles.

Country Status (9)

Country Link
US (1) US5593693A (es)
EP (2) EP0867426B1 (es)
JP (1) JPH07223937A (es)
CN (1) CN1096279C (es)
AT (2) ATE219762T1 (es)
CA (1) CA2131515C (es)
DE (3) DE59410143D1 (es)
DK (1) DK0642784T3 (es)
ES (1) ES2133454T3 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283029B1 (it) * 1996-05-17 1998-04-03 Resa Farma Composizioni farmaceutiche a base di diclofenac
US6974595B1 (en) 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
US7687542B2 (en) 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
DE59808063D1 (de) * 1998-06-03 2003-05-28 Gergely Dr & Co Mit Alkali- bzw. Erdalkali-Ionen dotierte Zitronensäure
US6121215A (en) * 1999-08-27 2000-09-19 Phyzz, Inc. Foaming effervescent bath product
ES2196689T3 (es) * 1999-09-09 2003-12-16 Gergely Dr & Co Granulado efervescente con efervescencia retardada.
US6432450B1 (en) 1999-09-09 2002-08-13 Gerhard Gergely Effervescent granules with delayed effervescent effect
FR2811531A1 (fr) * 2000-07-12 2002-01-18 Bionatec Produit pour le maintien d'objets decoratifs, procede de fabrication et d'utilisation dudit produit
CN1643133A (zh) * 2002-03-25 2005-07-20 华盛顿大学 嵌合胰腺
AU2002350719A1 (en) * 2002-11-29 2004-06-23 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP3216445A1 (en) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Oral therapeutic compound delivery system
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
EP3263117A1 (en) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US7700125B2 (en) 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
US7939561B2 (en) 2006-02-07 2011-05-10 Apr Applied Pharma Research S.A. Blister packaging for acute pain regimens
BRPI0714423B1 (pt) 2006-07-12 2016-10-04 Purac Biochem Bv partícula grau alimentício revestida com ácido parcialmente neutralizado, produto alimentício ou bebida, método para preparação da referida partícula e uso de ácido policarboxílico
WO2013052019A1 (en) * 2011-08-19 2013-04-11 Mahmut Bilgic Production method for effervescent formulations comprising diclofenac
WO2013109222A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Formulations comprising diclofenac as the active agent
EP3037387A1 (en) * 2014-12-22 2016-06-29 Solvay SA Alkali metal bicarbonate particles with exceptional flowability

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3165572D1 (en) * 1981-10-06 1984-09-20 Gergely Gerhard Process for manufacturing effervescent granules which may be transformed, when required, into effervescent tablets
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
GB2148117B (en) * 1983-09-28 1987-10-21 Gergely Gerhard An effervescent composition suitable for effervescent tablets
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
DE3627475A1 (de) * 1986-06-26 1988-01-14 Gergely Gerhard Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
DE3838431A1 (de) 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
IT1246350B (it) * 1990-07-11 1994-11-17 Eurand Int Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
WO1993000886A1 (de) 1991-07-01 1993-01-21 Gerhard Gergely Reaktionsdotierte brausesysteme
DE9300886U1 (de) * 1993-01-22 1993-05-27 Ebinger, Klaus, 5000 Köln Stabförmige Magnetometer-Sonde

Also Published As

Publication number Publication date
CA2131515C (en) 2006-08-29
CA2131515A1 (en) 1995-03-08
DE59410143D1 (de) 2002-08-01
EP0642784A1 (de) 1995-03-15
ATE219762T1 (de) 2002-07-15
EP0642784B1 (de) 1999-05-19
US5593693A (en) 1997-01-14
DK0642784T3 (da) 1999-11-22
EP0867426B1 (de) 2002-06-26
CN1096279C (zh) 2002-12-18
DE59408273D1 (de) 1999-06-24
CN1107366A (zh) 1995-08-30
EP0867426A2 (de) 1998-09-30
EP0867426A3 (en) 1998-11-11
ATE180164T1 (de) 1999-06-15
JPH07223937A (ja) 1995-08-22
DE9422239U1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
DK0642784T3 (da) Bruseblanding med alkalisalte eller lysinater af uopløseligt eller tungtopløseligt aktivstof
CA2290504A1 (en) Tablets, and process for making tablets
KR930703043A (ko) 소화 농축물로서 유용한 피막 형성형 발포성 수용액
AU9168298A (en) Aqueous solutions of salicylic acid derivatives
ATE117199T1 (de) Reaktionsdotierte brausesysteme.
HK33192A (en) Pharmaceutical compositions
WO2007078460A3 (en) Foaming, color-changing topical composition and method of imparting a cosmetic effect
CA2389292A1 (en) Absorbent article which maintains prolonged natural skin ph
DE69918074D1 (de) Makrolid-formulierung mit verzögerter wirkstoffabgabe
IE871730L (en) Calcium compositions
WO2001037816A3 (en) Coating of tablet cores
EP0678031A4 (en) TISSUE GROWTH INHIBITORS FROM TISSUE, METHODS FOR THEIR PRODUCTION AND USE THEREOF.
NO903863D0 (no) Tiazolidindionderivater som hypoglykemiske midler.
FR2666508B1 (fr) Compositions pharmaceutiques contenant des derives de furanne.
DE3750025D1 (de) Zytostatisch wirksame Anthracyclinderivate.
DE69821001D1 (de) Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält
ATE140955T1 (de) Wieder freisetzbare umhuellte aktive substrate
NO913019L (no) Faste orale preparatformer som inneholder ifosfamid som virksomt stoff.
NO940844D0 (no) Farmasöytisk aktive hydroksykarboksylsyrederivater
AU5177390A (en) Pyridine derivatives and their salts, and insecticidal/acaricidal agent containing the same as active ingredient
TW238250B (es)
JPS5283515A (en) N-dimethyl-1- (l-(-)-alpha-hydroxy-omega-aminoalkanoyl) -xk-62-2
SE9002495L (sv) Medel foer minskning av immisionsskador paa skog
ITMI932678A0 (it) Derivati metallorganici degli acidi s-acil-2-(s)-(2-pirrolidon-5-(s)- carbonilamido)-3-mercapto propionici con zinco, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
RU99110019A (ru) Способ хранения плодов или овощей

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 642784

Country of ref document: ES